ELIOS: Following cataract surgery, surgeon will proceed to ELIOS treatment.
Competitor Device: Following cataract surgery, surgeon will proceed to Competitor treatment.
The primary study objective is to compare the effectiveness of the combination of phacoemulsification with intraocular lens implant with ELIOS or competitor device in reducing IOP at 12 months postoperatively.
| Facility | City | Region | Status |
|---|---|---|---|
| ELIOS Clinical Site | Leuven | Belgium | Recruiting |
| Elios Clinical Site | Avranches | France | Recruiting |
| ELIOS Clinical Site | Bordeaux | France | Recruiting |
| ELIOS clinical site | Paris | France | Recruiting |
| ELIOS Clinical Site | Bochum | Germany | Recruiting |
| Elios clinical site | Bonn | Germany | Recruiting |
| ELIOS clinical site | Heidelberg | Germany | Recruiting |
| ELIOS Clinical Site | Maastricht | Netherlands | Recruiting |
| ELIOS clinical site | Barcelona | Spain | Recruiting |
| ELIOS Clincal Site | Madrid | Spain | Recruiting |
| ELIOS Clinical site | Madrid | Spain | Recruiting |
| ELIOS Clinical Site | East Grinstead | United Kingdom | Recruiting |
| ELIOS Clinical Site | Edinburgh | United Kingdom | Recruiting |
| ELIOS Clinical Site | Guildford | United Kingdom | Recruiting |
| ELIOS clinical site | London | United Kingdom | Recruiting |
| ELIOS Clinical Site | Manchester | United Kingdom | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06246136 on ClinicalTrials.gov ↗ ← All trials in the UK